CitraFlow™ 4%, 30% and 46.7% prefilled syringes are a proven alternative to heparin for flushing and locking catheters/ports on patients. Sodium citrate avoids the risks associated with systemic heparinisation and is safe for use in patients with suspected or confirmed Heparin Induced Thrombocytopenia.
Clinical studies have shown that the use of ananticoagulant Sodium Citrate solution to lock central venous catheters has significant advantages compared to existing standards of care.
CitraFlow™ is highly effective in maintaining catheter patency, works as an anticoagulant and decreases the incidence of infection.
CitraFlow™ is designed for use in a sterile field.